University of Arizona researchers combined label-free multiphoton microscopy with neural networks to accurately classify pancreatic neuroendocrine neoplasms in tissue samples.
Key Details
- 1Multiphoton microscopy (MPM) was used to image pancreatic neuroendocrine neoplasm (PNEN) samples without labeling.
- 2Researchers trained both traditional machine learning and four convolutional neural networks (CNNs) on these images.
- 3CNNs achieved classification accuracies ranging from 90.8% to 96.4%, outperforming the ML algorithm’s 80.6%.
- 4Analysis showed key features included collagen content and image texture metrics.
- 5The approach is faster than traditional pathology and was validated across samples from multiple biorepositories.
- 6Publication: Biophotonics Discovery, October 2, 2025, DOI: 10.1117/1.BIOS.2.4.045001.
Why It Matters
This study demonstrates the potential of advanced imaging and AI for real-time, highly accurate tumor detection, which could transform intraoperative pathology and improve surgical outcomes in oncology. Faster, label-free diagnosis may reduce delays and error in tumor identification during surgery.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.